124341-38-4

Basic information

• Product Name: Benzoic acid, 2-(methylamino)-3-nitro- (9CI)
• Synonyms: Benzoic acid, 2-(methylamino)-3-nitro- (9CI)
• CAS NO: 124341-38-4
• Molecular Formula: C₈H₈N₂O₄
• Molecular Weight: 196.16012
• Product Categories: AMINOACID
• Mol File: 124341-38-4.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzoic acid, 2-(methylamino)-3-nitro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-(methylamino)-3-nitro- (9CI)(124341-38-4)
• EPA Substance Registry System: Benzoic acid, 2-(methylamino)-3-nitro- (9CI)(124341-38-4)

Safety Data

• Hazardous Substances Data: 124341-38-4(Hazardous Substances Data)

Upstream product

• 317-46-4 2-fluoro-3-nitro-benzoic acid 
• 593-51-1 methylamine hydrochloride 
• 74-89-5 methylamine 
• 573-54-6 2-bromo-3-nitro-benzoic acid 
• 3970-35-2 2-chloro-3-nitrobezoic acid 
• 119-68-6 N-Methylanthranilic acid 

Downstream Products

• 24133-87-7 1-methyl-7-nitro-2.3 -dihydro-1H-1,3-benzodiazol-2-one 
• 124340-48-3 3-Methyl-2-phenyl-3H-benzoimidazole-4-carboxylic acid (2-dimethylamino-ethyl)-amide 
• 124340-81-4 3-methyl-2-phenyl-1H-benzimidazole-4-carboxylic acid 
• 119-68-6 N-Methylanthranilic acid 
• 766491-67-2 3-amino-2-methylamino-benzoic acid 

Relevant articles and documents

TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE

This disclosure relates to bivalent compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the bivalent compounds, and to methods of use the bivalent compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such bivalent compounds.

MDM2 DEGRADERS AND USES THEREOF

The present invention relates to compounds and methods useful for the modulation of mouse double minute 2 homolog ("MDM2") protein via ubiquitination and/or degradation by compounds according to the present invention.

TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE

Bivalent compounds, compositions comprising one or more of the bivalent compounds, and methods of use the bivalent compounds for the treatment of certain disease in a subject in need thereof are provided. Methods for identifying such bivalent compounds are provided, either.